MDalert.com is designed to help physicians in all specialties succeed in this new world of performance-driven healthcare.
April 13, 2021

European Committee Endorses Atezolizumab as First-Line NSCLC Treatment

By Adam Hochron

The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended approval of atezolizumab as a first-line treatment for adults with metastatic non-small cell lung cancer...

 
European Committee Endorses Atezolizumab as First-Line NSCLC Treatment
April 12, 2021

Rucaparib Extends PFS Over Chemotherapy for BRCA mutation Ovarian Cancer

By Adam Hochron

Rucaparib resulted in longer progression free survival compared with standard of care chemotherapy among patients with relapsed high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer who had a deleterious BRCA mutation...
Rucaparib Extends PFS Over Chemotherapy for BRCA mutation Ovarian Cancer
April 8, 2021

Meta-Analysis Examines Adverse Events for Ramucirumab in Patients with Advanced Solid Tumors

By Adam Hochron

With ramucirumab approved for the treatment of several advanced solid tumors, a recent systemic review and meta-analysis of ten randomized controlled trials looked at the risk-benefit of the drug across several solid tumor types...

Meta-Analysis Examines Adverse Events for Ramucirumab in Patients with Advanced Solid Tumors
March 31, 2021

Benralizumab Shows Benefits for Asthma, Nasal Polyp Treatment

By Adam Hochron

A phase 3b clinical trial studying benralizumab as a treatment for asthma and nasal polyps found the treatment provided benefits in several areas, including lung function and nasal polyps symptoms...

Benralizumab Shows Benefits for Asthma, Nasal Polyp Treatment
March 30, 2021

Rates of Brain Metastases Increased by 25% During the Pandemic

By Michael Vlessides, /alert Contributor

As if COVID-19 hasn’t claimed enough victims around the world, a United Kingdom research group has found another detrimental repercussion of the pandemic...

Rates of Brain Metastases Increased by 25% During the Pandemic
View More
Loading...

Trending News

In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.

Reuters Health Medical News

Healthy young adults may work-out less intensely wearing cloth masks

By Linda Carroll (Reuters Health) - Cloth masks worn by healthy young adults during intense workouts leads to lower exercise capacity and greater perceived discomfort, a small study suggests. An Read More »

Majority of Brazil COVID-19 ICU patients aged 40 years or younger - report

By Reuters Staff RIO DE JANEIRO (Reuters) - The surging COVID-19 outbreak in Brazil is increasingly affecting younger people, with hospital data showing that last month the majority of those in Read More »

One in four parents say youth sports don't consistently enforce COVID-19 precautions

By Lisa Rapaport (Reuters Health) - Even though the majority of parents give youth sports leagues high marks for keeping them informed about COVID-19 safety protocols, more than one in four parents Read More »

Self-report smell loss tool could be useful for COVID-19 symptom screening

By Marilynn Larkin NEW YORK (Reuters Health) - A novel self-administered olfactory test, SCENTinel, identifies individuals with smell loss and will likely be useful for COVID-19 symptom screening and Read More »

U.S. FDA to scrutinize vaccine design behind COVID-19 shots linked to blood clots

By Julie Steenhuysen and Kate Kelland CHICAGO/LONDON (Reuters) - With two COVID-19 vaccines now under scrutiny for possible links to very rare cases of blood clots in the brain, U.S. government Read More »

Comfort care for stroke on the rise in the U.S., tied to lower costs

By Marilynn Larkin NEW YORK (Reuters Health) - Comfort-care interventions among ischemic-stroke patients increased in the U.S. from 2006 to 2015 and were associated with lower adjusted costs, Read More »

Moderna says protection from its COVID-19 vaccine still strong six months on

By Michael Erman NEW YORK (Reuters) - Moderna Inc said on Tuesday that its COVID-19 vaccine still showed strong protection against the illness six months after people received their second shot, with Read More »

Breastfeeding safe for mothers with COVID-19 infection

By Reuters Staff NEW YORK (Reuters Health) - SARS-CoV-2 is unlikely to be transmitted to newborns via breast milk, according to a study from Israel, which supports the current guidance from the World Read More »

See all news »

Clinical Trials

Use our ClinicalTrials.gov feed to find trials in which your patients could enroll. In some cases, experimental drugs are a patient’s only hope. This section will regularly report on trials in the most common disease states, as they are getting underway.


© 2021 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use
Do Not Sell My Personal Information